A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Daptomycin for the treatment of gram-positive periprosthetic hip infections: Can daptomycin prevent the implant removal?
[post]
2019
unpublished
Management of periprosthetic hip infections (PHIs) generally consists of implant removal and thorough debridement, accompanied by appropriate antibiotic therapy. Daptomycin (DAP) is a novel antibiotic, which allowed for implant retention in several patients after treating their infected joints. However, there is no consensus about implant retention or removal during treatment of PHIs. The aim of this study was to examine the effect of DAP, and to determine a surgical treatment strategy.
doi:10.21203/rs.2.16186/v1
fatcat:qs27f5atvvcjpnuzr2u4l4rf3e